Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2016 | 1 |
2020 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Special endpoint and product specific considerations in pharmaceutical acceptable daily exposure derivation.
Regul Toxicol Pharmacol. 2016 Aug;79 Suppl 1:S79-93. doi: 10.1016/j.yrtph.2016.05.022. Epub 2016 May 24.
Regul Toxicol Pharmacol. 2016.
PMID: 27233924
Review.
Development of Duration-Based Non-Mutagenic Thresholds of Toxicological Concern (TTCs) Relevant to Parenteral Extractables and Leachables (E&Ls).
Masuda-Herrera MJ, Bercu JP, Broschard TH, Burild A, Hasselgren C, Parris P, Ford LC, Graham J, Stanard B, Comerford M, Lettiere D, Erler S, Callis CM, Morinello E, Muster W, Martin EA, Griffin TR, Nagao L, Cruz M.
Masuda-Herrera MJ, et al. Among authors: callis cm.
PDA J Pharm Sci Technol. 2022 Sep-Oct;76(5):369-383. doi: 10.5731/pdajpst.2021.012693. Epub 2022 Jan 14.
PDA J Pharm Sci Technol. 2022.
PMID: 35031541
Item in Clipboard
Setting impurity limits for endogenous substances: Recommendations for a harmonized procedure and an example using fatty acids.
Jolly RA, Bandara S, Bercu J, Callis CM, Dolan DG, Graham J, HaMai D, Barle EL, Maier A, Masuda-Herrera M, Moudgal C, Parker JA, Reichard J, Sandhu R, Fung ES.
Jolly RA, et al. Among authors: callis cm.
Regul Toxicol Pharmacol. 2022 Oct;134:105242. doi: 10.1016/j.yrtph.2022.105242. Epub 2022 Aug 11.
Regul Toxicol Pharmacol. 2022.
PMID: 35964842
Item in Clipboard
Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies.
Parris P, Martin EA, Stanard B, Glowienke S, Dolan DG, Li K, Binazon O, Giddings A, Whelan G, Masuda-Herrera M, Bercu J, Broschard T, Bruen U, Callis CM, Stults CLM, Erexson GL, Cruz MT, Nagao LM.
Parris P, et al. Among authors: callis cm.
Regul Toxicol Pharmacol. 2020 Dec;118:104802. doi: 10.1016/j.yrtph.2020.104802. Epub 2020 Oct 7.
Regul Toxicol Pharmacol. 2020.
PMID: 33038429
Item in Clipboard
In silico approaches to predicting cancer potency for risk assessment of genotoxic impurities in drug substances.
Bercu JP, Morton SM, Deahl JT, Gombar VK, Callis CM, van Lier RB.
Bercu JP, et al. Among authors: callis cm.
Regul Toxicol Pharmacol. 2010 Jul-Aug;57(2-3):300-6. doi: 10.1016/j.yrtph.2010.03.010. Epub 2010 Apr 2.
Regul Toxicol Pharmacol. 2010.
PMID: 20363275
Item in Clipboard
Cite
Cite